Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

PCSK9 Polyclonal antibody

PCSK9 Polyclonal Antibody for WB, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat and More (1)

Applications

WB, IHC, IF, ChIP, ELISA

EC:3.4.21.-, FH3, HCHOLA3, LDLCQ1, NARC 1

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for PCSK9 in ?

Tested Applications

Positive WB detected inHepG2 cells, rat brain tissue, L02 cells, 4T1 cells
Positive IHC detected inhuman colon cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:250-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

55206-1-AP targets PCSK9 in WB, IHC, IF, ChIP, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse, rat, hamster
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

Peptide

Predict reactive species
Full Name proprotein convertase subtilisin/kexin type 9
Calculated Molecular Weight 74 kDa
Observed Molecular Weight 58-62 kDa, 72-78 kDa
GenBank Accession NumberNM_174936
Gene Symbol PCSK9
Gene ID (NCBI) 255738
RRIDAB_10918272
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ8NBP7
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a crucial protein governing the circulating levels of low density lipoprotein-cholesterol (LDL-C), by virtue of its pivotal role in the degradation of the LDL receptor (LDLR). PCSK9 is expressed in the kidney and lung. It is synthesized as a 72 kDa immature precursor that undergoes autocatalytic cleavage in the endoplasmic reticulum to generate a 63 kDa mature protein. The cleaved N-terminal fragment remains associated with the mature protein and is necessary for its secretion, allowing it to circulate in the blood. The ability of PCSK9 to regulate a diverse group of cell-surface proteins hinted that it might also be able to influence additional membrane proteins that are important in anti-tumour immune responses. Targeting PCSK9 to treat cancer is also attractive because two neutralizing antibodies against it, evolocumab and alirocumab, have already been approved for human clinical use to lower cholesterol levels. (PMID: 30522786, PMID: 22493497)

Protocols

Product Specific Protocols
IHC protocol for PCSK9 antibody 55206-1-APDownload protocol
WB protocol for PCSK9 antibody 55206-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The PCSK9 Polyclonal antibody (Cat# 55206-1-AP) has 73 citations across journals including Nature, Nature Communications, Metabolism, Acta Pharmacologica Sinica, Journal of Nanobiotechnology, Cell Reports, and International Journal of Molecular Sciences. Research fields span lipid metabolism, atherosclerosis, cardiovascular disease, cancer (hepatocellular, lung, breast, pancreatic), neurodegeneration, reproductive health, renal disease, and novel PCSK9-targeted drug development.

SpeciesApplicationTitle
mouse,humanWB

Nature

Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer.

Authors - Xinjian Liu
  • KO Validated
human, mouseWB,IHC

Cancer Commun (Lond)

Lipid metabolism reprograming by SREBP1-PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy

Authors - Mengyi Lao
  • KO Validated
mouseWB

Nat Commun

A strategy for Cas13 miniaturization based on the structure and AlphaFold

Authors - Feiyu Zhao
humanIHC

Exp Hematol Oncol

PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma.

Authors - Shi-Zhe Zhang
  • KD Validated
mouseWB,IHC

Metabolism

Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome.

Authors - Meijiao Wang

Metabolism

CADD-engineered peptide protacs efficiently target PCSK9 for hypercholesterolemia in vivo.

Authors - Gang Fan

Reviews

    5.0 out of 5
Add a review

1 verified customer reviews

What customers say

The single review for this antibody reports excellent performance in immunohistochemistry on hepatic tissue. The user rated it 5 out of 5 stars and noted that it works very well at a 1/100 dilution, particularly at pH 6. Overall, the feedback highlights strong staining results and reliable performance for IHC applications.

The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.


Malak (Verified Customer) (11-30-2020)

The antibody works very well in IHC staining especially at pH6 and 1/100 dilution

  • Applications: Immunohistochemistry
  • Primary Antibody Dilution: 1/100
  • Cell Tissue Type: Hepatic tissue
Loading...
||
New chat

Able®

正在加载,请稍候...